Home Companies Catalysts Deep Dives

Autosomal dominant polycystic kidney disease

ADPKD · CVRM · 1 drugs · 2 indications

Competitive Landscape (1 drugs)
DrugCompanyMechanismModalityRouteStage
Jynarque / Samsca4578Vasopressin V2 Receptor AntagonistSmall moleculeORALAPPROVED
Indications (2)
ADPKD
Jynarque / Samsca APPROVED
Pediatric ARPKD
Jynarque / Samsca PHASE3
Data from Supabase · Updated 2026-03-24